

A pharmaceutical company has finally granted a dying child the medication that could heighten his chance of survival. In Memphis,

Josh Hardy, the little boy fighting for his life as an adenovirus infection ravages his body, has just been enrolled

Chimerix, a drug company that manufactures the still-developmental drug Brincidofovir, is denying the potentially lifesaving drug to 7-year-old Josh Hardy.